(NewsUSA) - It seems that every day there’s new information about advances in the fight against cancer. In just the past decade, many medicines have changed the way some cancers are treated, adding months, and sometimes years, to patient’s lives.

Now, doctors are looking at how some of these available medicines can keep cancer from returning after surgery by using them earlier -; before the cancer has returned or spread to other organs.

For example, for patients with a rare form of stomach cancer known as GIST, there is good news. The U.S. FDA recently approved Gleevec (imatinib mesylate) tablets as the first drug to reduce the risk of these tumors coming back after surgery. Gleevec is now the only post-surgery treatment approved to slow the return of this life-threatening cancer.
Read more

(NewsUSA) - Men facing a diagnosis of prostate cancer have more treatment options than ever before, according to the American Society for Radiation Oncology.

Prostate cancer is the most common cancer in American men. The American Cancer Society reports that, in 2008, one-quarter of all cancer diagnosed in men was prostate cancer.

But dramatic advances in treatments are allowing more men to beat the disease. Nearly 99 percent of men with prostate cancer now live five years or more after diagnosis.

Since there are several options, it’s important to discuss all the treatment methods with a radiation oncologist, a physician who specializes in treating diseases with radiation therapy, and a urologist, a surgeon who specializes in the urinary tract. They’ll help you decide which treatment plan is best for you. Possibilities include surgery, external beam radiation therapy, hormone therapy, chemotherapy or prostate brachytherapy.
Read more

Obesity associated with degeneratif disease, such as cancer. But unfortunately, many women associate the problems of poor between them. They feel more fear when body weight increased rather think that obesity is affected by cancer can make it.

Mirror, Tuesday (27/1/2009), report the results of a poll of 1000 women followed in the UK. In these poll results found that only 20 among 1000 women who put the fear of cancer as the biggest in their lives. As many as 30 other women have diabetes, while another 10 said heart disease.
Read more

Since long trusted garlic beneficial for health. Including against viruses, bacteria, to cancer cells. Really?

Garlic is popular as a culinary spice taste Satan and repellent in Mythology vampir. Beyond that, the plants called allium sativum latin this since the times of ancient also believed to have medical benefits, such as against viruses, bacteria, and cancer, and lower cholesterol. Not surprisingly, garlic is also considered as a “wonderful herbal medicine.”

However, the findings of a new study concludes that the evidence that garlic associate with a reduction in the risk of cancer and less than still very minimal.
Read more

Taking menopause hormones for five years doubles the risk for breast cancer, according to a new analysis of a big federal study that reveals the most dramatic evidence yet of the dangers of these still-popular pills.

Even women who took estrogen and progestin pills for as little as a couple of years had a greater chance of getting cancer. And when they stopped taking them, their odds quickly improved, returning to a normal risk level roughly two years after quitting.
Read more

In a new tactic in the fight against cancer, Cornell researcher Michael King has developed what he calls a lethal “lint brush” for the blood — a tiny, implantable device that captures and kills cancer cells in the bloodstream before they spread through the body.

The strategy, which takes advantage of the body’s natural mechanism for fighting infection, could lead to new treatments for a variety of cancers, said King, who is an associate professor of biomedical engineering.

In research conducted at the University of Rochester and to be published in an upcoming issue of the journal Biotechnology and Bioengineering, King showed that two naturally occurring proteins can work together to attract and kill as many as 30 percent of tumor cells in the bloodstream — without harming healthy cells.
Read more

Overall, your chances of dying of breast cancer are lower if you get regular screening mammograms. But a new study points out that an unadvertised cost of screening includes the possibility that you’ll be diagnosed with, and treated for a cancer that was not going to hurt you.

Despite the appeal of early detection, some mammograms may locate some cancers that would have otherwise regressed, according to the study, which appeared in the Archives of Internal Medicine.

In four Norwegian countries, breast cancer rates increased significantly after women there began undergoing mammography every two years.
Read more

(Corrects 13th paragraph to clarify that Avastin is not a pill)

A broad analysis of genes has turned up 26 mutations linked with the most common form of lung cancer, several of which play a role in other cancers as well, researchers said on Wednesday.

The findings, published in the journal Nature, double the number of genes already linked with lung adenocarcinoma, a type of non-small cell lung cancer that accounts for 40 percent of the more than 1 million lung cancer deaths each year.

“We think that our study may achieve a real impact on the cure of lung cancer patients,” Dr. Matthew Meyerson of the Broad Institute of Massachusetts Institute of Technology and Harvard University said in a telephone briefing.
Read more

We generally think of breast cancer as being only a problem for women; but breast cancer can also occur in men, although far less often than in women. On average, breast cancer occurs in less than 1 in 1,000 American men and accounts for less than 0.5 percent of all cancer deaths in men.

If a man carries a BRCA2 mutation, however, he has a much greater lifetime risk (about 7 percent) of developing breast cancer. He also faces an increased risk of prostate cancer. BRCA1 mutations are less likely than BRCA2 mutations to predispose men to breast cancer.

A man should ask his doctor about a screening test for mutations in his BRCA genes if:

* several close female relatives have a history of breast or ovarian cancer
* a first-degree relative — mother, sister, brother, or offspring — develops breast cancer before age 50, or has had a positive test for a BRCA gene mutation
Read more

Sellheart via Health News

The millions of Americans who are overweight or obese are putting their health in jeopardy. Obesity is the second leading cause of preventable death, and can raise your risk of developing heart disease, cancer, diabetes, arthritis, asthma and even gum disease. The underlying causes of obesity are numerous, from genetic disposition to binge eating, which may be caused by the same brain changes responsible for addiction. This link prompted researchers to test a potential addiction drug on lab rats bred to be obese-with surprising results.

Researchers at the U.S. Department of Energy’s Brookhaven National Laboratory tested the drug, called vigabatrin or GVG, in 50 rats, some of which were bred obese and some were of normal weight. The animals were either given injections of various amounts of vigabatrin or a placebo for up to 40 days. The genetically obese rats lost up to 19 percent of their body weight, and normal-weight rats lost 12 to 20 percent of their body weight. “Our results appear to demonstrate that vigabratrin induced satiety in these animals,” said Amy DeMarco, who worked on the study. “When we gave GVG, they would steadily lose weight, and when we took them off GVG, they would steadily gain weight,” she told Reuters Health. Read more